Mayinglong Pharmaceutical Group Co Ltd (600993) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.031x

Based on the latest financial reports, Mayinglong Pharmaceutical Group Co Ltd (600993) has a cash flow conversion efficiency ratio of 0.031x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥139.20 Million ≈ $20.37 Million USD) by net assets (CN¥4.43 Billion ≈ $648.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Mayinglong Pharmaceutical Group Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Mayinglong Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)

This chart illustrates how Mayinglong Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Mayinglong Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mayinglong Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Mayinglong Pharmaceutical Group Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Vedant Fashions Limited NSE:MANYAVAR	0.035x
Prosegur MC:PSG	0.009x
American Superconductor Corporation NASDAQ:AMSC	0.028x
Clariane SE PA:CLARI	0.070x
BlackRock ESG Capital Allocation Trust NYSE:ECAT	N/A
Wondershare Technology Co Ltd Class A SHE:300624	0.036x
Healthcare Services Group Inc NASDAQ:HCSG	0.048x
Zhejiang Guyuelongshan Shaoxing Wine Co Ltd SHG:600059	-0.006x

Annual Cash Flow Conversion Efficiency for Mayinglong Pharmaceutical Group Co Ltd (2003–2025)

The table below shows the annual cash flow conversion efficiency of Mayinglong Pharmaceutical Group Co Ltd from 2003 to 2025. View Mayinglong Pharmaceutical Group Co Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥4.51 Billion ≈ $660.65 Million	CN¥600.44 Million ≈ $87.86 Million	0.133x	+12.29%
2024-12-31	CN¥4.20 Billion ≈ $614.78 Million	CN¥497.61 Million ≈ $72.82 Million	0.118x	-24.12%
2023-12-31	CN¥3.87 Billion ≈ $566.29 Million	CN¥604.07 Million ≈ $88.39 Million	0.156x	+65.24%
2022-12-31	CN¥3.62 Billion ≈ $529.55 Million	CN¥341.85 Million ≈ $50.02 Million	0.094x	-47.57%
2021-12-31	CN¥3.31 Billion ≈ $484.97 Million	CN¥597.17 Million ≈ $87.38 Million	0.180x	+87.62%
2020-12-31	CN¥2.95 Billion ≈ $431.18 Million	CN¥282.99 Million ≈ $41.41 Million	0.096x	-48.52%
2019-12-31	CN¥2.63 Billion ≈ $385.58 Million	CN¥491.58 Million ≈ $71.93 Million	0.187x	+42.35%
2018-12-31	CN¥2.35 Billion ≈ $344.15 Million	CN¥308.24 Million ≈ $45.11 Million	0.131x	-16.43%
2017-12-31	CN¥2.27 Billion ≈ $332.31 Million	CN¥356.17 Million ≈ $52.12 Million	0.157x	+32.02%
2016-12-31	CN¥2.02 Billion ≈ $295.13 Million	CN¥239.60 Million ≈ $35.06 Million	0.119x	+22.57%
2015-12-31	CN¥1.89 Billion ≈ $276.06 Million	CN¥182.85 Million ≈ $26.76 Million	0.097x	+47.44%
2014-12-31	CN¥1.70 Billion ≈ $248.58 Million	CN¥111.67 Million ≈ $16.34 Million	0.066x	-20.76%
2013-12-31	CN¥1.57 Billion ≈ $229.19 Million	CN¥129.94 Million ≈ $19.01 Million	0.083x	-29.74%
2012-12-31	CN¥1.43 Billion ≈ $209.74 Million	CN¥169.25 Million ≈ $24.77 Million	0.118x	+106.81%
2011-12-31	CN¥1.32 Billion ≈ $193.15 Million	CN¥75.37 Million ≈ $11.03 Million	0.057x	+663.58%
2010-12-31	CN¥1.13 Billion ≈ $164.95 Million	CN¥-11.42 Million ≈ $-1.67 Million	-0.010x	-104.93%
2009-12-31	CN¥1.05 Billion ≈ $153.90 Million	CN¥216.11 Million ≈ $31.62 Million	0.205x	+74.55%
2008-12-31	CN¥871.43 Million ≈ $127.52 Million	CN¥102.59 Million ≈ $15.01 Million	0.118x	+1448.66%
2007-12-31	CN¥853.12 Million ≈ $124.84 Million	CN¥6.49 Million ≈ $948.97K	0.008x	-91.36%
2006-12-31	CN¥855.21 Million ≈ $125.14 Million	CN¥75.27 Million ≈ $11.01 Million	0.088x	-10.15%
2005-12-31	CN¥596.55 Million ≈ $87.29 Million	CN¥58.43 Million ≈ $8.55 Million	0.098x	-0.19%
2004-12-31	CN¥552.20 Million ≈ $80.80 Million	CN¥54.19 Million ≈ $7.93 Million	0.098x	-66.37%
2003-12-31	CN¥231.35 Million ≈ $33.85 Million	CN¥67.52 Million ≈ $9.88 Million	0.292x	--

About Mayinglong Pharmaceutical Group Co Ltd

SHG:600993 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.43 Billion

CN¥9.77 Billion CNY

Market Cap Rank

#7458 Global

#1631 in China

Share Price

CN¥22.67

Change (1 day)

+1.07%

52-Week Range

CN¥21.55 - CN¥30.12

All Time High

CN¥31.68